Chung Wook Chung Selected Research

Pancreatitis

11/2011

Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chung Wook Chung Research Topics

Disease

3	Neoplasms (Cancer) 08/2014 - 01/2010
1	Cholangiocarcinoma 01/2013
1	Pancreatitis 11/2011
1	Gastric Outlet Obstruction 01/2010

Drug/Important Bio-Agent (IBA)

1	Cisplatin (Platino)FDA LinkGeneric 08/2014
1	PolymersIBA 01/2013
1	Dextrans (Dextran)FDA Link 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	polyhistidineIBA 01/2013
1	nafamostatIBA 11/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2011

Therapy/Procedure

1	Self Expandable Metallic Stents 01/2010
1	Stents 01/2010
1	Palliative Care (Palliative Therapy) 01/2010